21 CFR 862.1250
§ 862.1250 Desoxycorticosterone test system.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 862.1250, § 862.1250 Desoxycorticosterone test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89090
- Permanent ID
ys:prov:89090@1- SHA-256
df67151fc447515823bc1cfc3dd80bf7db1a818477ea8869fdfc36dfa736e3e6
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. A desoxycorticosterone test system is a device intended to measure desoxycorticosterone (DOC) in plasma and urine. DOC measurements are used in the diagnosis and treatment of patients with hypermineralocorticoidism (excess retention of sodium and loss of potassium) and other disorders of the adrenal gland.
(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.